Smyth, Brendan
85  results:
Search for persons X
?
1

Kidney and Cardiovascular Effects of Canagliflozin Accordin..:

Yi, Tae Won ; Smyth, Brendan ; Di Tanna, Gian Luca...
https://research.rug.nl/en/publications/3c7942ae-2565-40e5-83bd-03275fb620a8.  , 2023
 
?
2

WCN23-0764 KIDNEY SUPPORTIVE CARE: A SURVEY OF ACTIVITY AND..:

Snead, Charlotte M ; Hole, Barnaby ; Agarwal, Neeru...
Snead , C M , Hole , B , Agarwal , N , O'Hara , D , Stallworthy , E , Caskey , F J , Smyth , B & Ducharlet , K 2023 , ' WCN23-0764 KIDNEY SUPPORTIVE CARE: A SURVEY OF ACTIVITY AND PRACTICE PATTERNS ACROSS AUSTRALIA, NEW ZEALAND AND THE UNITED KINGDOM ' , pp. S373-S374 . https://doi.org/10.1016/j.ekir.2023.02.842.  , 2023
 
?
3

Feasibility of Symptom monitoring WIth Feedback Trial (SWIF..:

Agarwal, Neeru ; Shah, Karan K ; Dansie, Kathryn...
Agarwal , N , Shah , K K , Dansie , K , Bennett , P N , Greenham , L , Brown , C , Smyth , B , McDonald , S , Jesudason , S , Viecelli , A K , Morton , R L & Caskey , F J 2023 , ' Feasibility of Symptom monitoring WIth Feedback Trial (SWIFT) for adults on hemodialysis : a registry-based cluster randomized pilot trial ' , BMC Nephrology , vol. 24 , no. 1 , 345 . https://doi.org/10.1186/s12882-023-03399-5.  , 2023
 
?
 
?
5

The sodium-glucose cotransporter-2 inhibitor canagliflozin ..:

Kang, Amy ; Smyth, Brendan ; Neuen, Brendon L...
https://research.rug.nl/en/publications/794013cf-f21c-4d11-b3f1-b52bab6160d9.  , 2023
 
?
6

WCN23-0481 Variation in Symptom Management Approaches in Ad..:

O'Hara, Daniel ; Agarwal, Neeru ; Hole, Barnaby...
O'Hara , D , Agarwal , N , Hole , B , Snead , C M , Stallworthy , E , Caskey , F J , Ducharlet , K & Smyth , B 2023 , ' WCN23-0481 Variation in Symptom Management Approaches in Advanced Kidney Disease ' , pp. S371-S372 . https://doi.org/10.1016/j.ekir.2023.02.840.  , 2023
 
?
10

The impact of canagliflozin on the risk of neuropathy event..:

Liao, Jinlan ; Kang, Amy ; Xia, Chao...
https://research.rug.nl/en/publications/ae3301b5-9f2d-4728-a634-0dba56515569.  , 2022
 
?
11

The impact of canagliflozin on the risk of neuropathy event..:

Liao, Jinlan ; Kang, Amy ; Xia, Chao...
https://discovery.ucl.ac.uk/id/eprint/10144060/1/1-s2.0-S1262363622000143-main.pdf.  , 2022
 
?
 
?
13

The Symptom Monitoring with Feedback Trial (SWIFT):protocol..:

Greenham, Lavern ; Bennett, Paul N ; Dansie, Kathryn...
Greenham , L , Bennett , P N , Dansie , K , Viecelli , A K , Jesudason , S , Mister , R , Smyth , B , Westall , P , Herzog , S , Brown , C , Handke , W , Palmer , S C , Caskey , F J , Couchoud , C , Simes , J , McDonald , S P & Morton , R L 2022 , ' The Symptom Monitoring with Feedback Trial (SWIFT) : protocol for a registry‑based cluster randomised controlled trial in haemodialysis ' , Trials , vol. 23 , no. 1 , 419 . https://doi.org/10.1186/s13063-022-06355-0.  , 2022
 
?
15

129-LB: Kidney and Cardiovascular Effects of Canagliflozin ..:

Yi, Tae Won ; Smyth, Brendan ; Kang, Amy...
https://discovery.ucl.ac.uk/id/eprint/10142600/3/Wheeler_Kidney%20and%20Cardiovascular%20Effects%20of%20Canagliflozin%20According%20to%20Age%20and%20Sex%20in%20the%20CREDENCE%20Trial_AAM.pdf.  , 2021
 
1-15